Company intelligence / Profile preview

eZono

Jena, Thuringia, Germany

Ownership: Private
Development stage: Other

Overview

eZono's ultrasound devices, notably the eZono 3000, 4000, and 5000, are CE- and FDA-cleared, commercially available worldwide, with demonstrated adoption in regional anesthesia, emergency care, and musculoskeletal applications. Their eZGuide technology provides real-time freehand needle navigation and is well received for improving precision and safety in procedures.

Therapeutic areas: CardiovascularOtherRheumatology
Modalities: Device
Industry: Medical Imaging

Partnerships

MVM Life Science Partners (investor, board participation)

Beyond the preview

Go deeper on eZono.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on eZono.

Explore the full profile